Jeisson Augusto Osorio - Academia.edu (original) (raw)

Jeisson Augusto Osorio

Uploads

Papers by Jeisson Augusto Osorio

Research paper thumbnail of NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer

BMC pulmonary medicine, Jan 13, 2017

NKX2-1, a key molecule in lung development, is highly expressed in non-small cell lung cancer (NS... more NKX2-1, a key molecule in lung development, is highly expressed in non-small cell lung cancer (NSCLC), particularly in lung adenocarcinoma (ADK), where it is a diagnostic marker. Studies of the prognostic role of NKX2-1 in NSCLC have reported contradictory findings. Two microRNAs (miRNAs) have been associated with NKX2-1: miR-365, which targets NKX2-1; and miR-33a, which is downstream of NKX2-1. We have examined the effect of NKX2-1, miR-365 and miR-33a on survival in a cohort of early-stage NSCLC patients and in sub-groups of patients classified according to the mutational status of TP53, KRAS, and EGFR. mRNA and miRNA expression was determined using TaqMan assays in 110 early-stage NSCLC patients. TP53, KRAS, and EGFR mutations were assessed by Sanger sequencing. NKX2-1 expression was upregulated in never-smokers (P = 0.017), ADK (P < 0.0001) and patients with wild-type TP53 (P = 0.001). A negative correlation between NKX2-1 and miR-365 expression was found (ρ = -0.287; P = 0.0...

Research paper thumbnail of Should the diagnosis and management of OSA move into general practice?

Research paper thumbnail of Extensions of Lipschitz mappings into a Hilbert space

Conference on Modern Analysis and Probability, 1984

Research paper thumbnail of NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer

BMC pulmonary medicine, Jan 13, 2017

NKX2-1, a key molecule in lung development, is highly expressed in non-small cell lung cancer (NS... more NKX2-1, a key molecule in lung development, is highly expressed in non-small cell lung cancer (NSCLC), particularly in lung adenocarcinoma (ADK), where it is a diagnostic marker. Studies of the prognostic role of NKX2-1 in NSCLC have reported contradictory findings. Two microRNAs (miRNAs) have been associated with NKX2-1: miR-365, which targets NKX2-1; and miR-33a, which is downstream of NKX2-1. We have examined the effect of NKX2-1, miR-365 and miR-33a on survival in a cohort of early-stage NSCLC patients and in sub-groups of patients classified according to the mutational status of TP53, KRAS, and EGFR. mRNA and miRNA expression was determined using TaqMan assays in 110 early-stage NSCLC patients. TP53, KRAS, and EGFR mutations were assessed by Sanger sequencing. NKX2-1 expression was upregulated in never-smokers (P = 0.017), ADK (P < 0.0001) and patients with wild-type TP53 (P = 0.001). A negative correlation between NKX2-1 and miR-365 expression was found (ρ = -0.287; P = 0.0...

Research paper thumbnail of Should the diagnosis and management of OSA move into general practice?

Research paper thumbnail of Extensions of Lipschitz mappings into a Hilbert space

Conference on Modern Analysis and Probability, 1984

Log In